These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 17911186

  • 1. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A, Wallis DE, Hursting MJ, Katz E, Lewis BE.
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
    [Abstract] [Full Text] [Related]

  • 2. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL, Hursting MJ, McCollum D.
    Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
    [Abstract] [Full Text] [Related]

  • 3. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, Argatroban-915 Investigators.
    Arch Intern Med; 2006 May; 163(15):1849-56. PubMed ID: 12912723
    [Abstract] [Full Text] [Related]

  • 4. Argatroban therapy in women with heparin-induced thrombocytopenia.
    Jang IK, Baron SJ, Hursting MJ, Anglade E.
    J Womens Health (Larchmt); 2007 May; 16(6):895-901. PubMed ID: 17678460
    [Abstract] [Full Text] [Related]

  • 5. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR, Pietrangeli CE, Hursting MJ.
    Drugs Aging; 2007 May; 24(6):489-99. PubMed ID: 17571914
    [Abstract] [Full Text] [Related]

  • 6. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ, Kelton JG, ARG-911 Study Investigators.
    Circulation; 2001 Apr 10; 103(14):1838-43. PubMed ID: 11294800
    [Abstract] [Full Text] [Related]

  • 7. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW, Bandyk DF, Bartholomew JR, Frame JN, Rice L.
    Am J Ther; 2011 Jan 10; 18(1):14-22. PubMed ID: 21079512
    [Abstract] [Full Text] [Related]

  • 8. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Hursting MJ, Levine RL, Leya F.
    Chest; 2006 Jun 10; 129(6):1407-16. PubMed ID: 16778256
    [Abstract] [Full Text] [Related]

  • 9. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV, Grossman EJ, Trevino SA, Hursting MJ, Murray PT.
    Ann Pharmacother; 2005 Oct 10; 39(10):1601-5. PubMed ID: 16131539
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
    Hursting MJ, Verme-Gibboney CN.
    J Cardiovasc Pharmacol; 2008 Dec 10; 52(6):561-6. PubMed ID: 19057393
    [Abstract] [Full Text] [Related]

  • 11. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM, McCollum DA, Hursting MJ.
    J Thromb Thrombolysis; 2006 Dec 10; 22(3):169-76. PubMed ID: 17103051
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH, Jung R, MacLaren R, Fish DN.
    Pharmacotherapy; 2005 Dec 10; 25(12):1736-45. PubMed ID: 16305293
    [Abstract] [Full Text] [Related]

  • 13. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.
    LaMonte MP, Brown PM, Hursting MJ.
    Crit Care Med; 2004 Apr 10; 32(4):976-80. PubMed ID: 15071388
    [Abstract] [Full Text] [Related]

  • 14. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S.
    Am J Cardiovasc Drugs; 2009 Apr 10; 9(4):261-82. PubMed ID: 19655821
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH, Durkalski VL, Nappi JM.
    Pharmacotherapy; 2006 Apr 10; 26(4):461-8. PubMed ID: 16553503
    [Abstract] [Full Text] [Related]

  • 16. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    Kondo LM, Wittkowsky AK, Wiggins BS.
    Ann Pharmacother; 2001 Apr 10; 35(4):440-51. PubMed ID: 11302409
    [Abstract] [Full Text] [Related]

  • 17. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
    Begelman SM, Hursting MJ, Aghababian RV, McCollum D.
    J Intern Med; 2005 Dec 10; 258(6):563-72. PubMed ID: 16313480
    [Abstract] [Full Text] [Related]

  • 18. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
    Murray PT, Hursting MJ.
    Ren Fail; 2006 Dec 10; 28(7):537-9. PubMed ID: 17050234
    [Abstract] [Full Text] [Related]

  • 19. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
    Hursting MJ, Soffer J.
    Drug Saf; 2009 Dec 10; 32(3):203-18. PubMed ID: 19338378
    [Abstract] [Full Text] [Related]

  • 20. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN, Rice L, Bartholomew JR, Whelton A.
    Clin Ther; 2010 Apr 10; 32(4):626-36. PubMed ID: 20435232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.